Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

IMAX reports before market open, meaning Day 0 captures the first full trading session of market reaction to results, while Day +1 reflects follow-through momentum.

Historical price behavior shows moderate initial reactions with occasional explosive follow-through moves. The stock has averaged a 2.75% absolute move on earnings day (Day 0) with a 5.86% intraday range, indicating controlled initial volatility. However, Day +1 tells a more dramatic story, with an average absolute move of 5.72% and a 7.99% range—suggesting the market often takes a full session to digest results and adjust positioning.

The most recent earnings on April 30, 2026, produced a modest +2.09% Day 0 gain followed by a -3.97% Day 1 decline, reflecting initial optimism that faded as investors processed the deceleration. In contrast, the February 2026 report saw a muted -0.84% Day 0 move explode into a +14.38% Day 1 surge—the largest single-day post-earnings gain in the dataset. This pattern of delayed reactions suggests traders should monitor not just the immediate response but the full 48-hour window, as IMAX often experiences its most significant moves on the day following the initial release.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 10.93% (±$4.32) for the August expiration, which is significantly larger than the historical average Day 0 move of 2.75% but roughly in line with the combined two-day average absolute move of 8.47%. This suggests options traders are anticipating above-average volatility, potentially reflecting uncertainty around the sustainability of the growth trajectory after Q1's slowdown.

Part 3: What Analysts Are Saying

Analysts maintain a bullish stance on IMAX with an average recommendation of 4.54 (between Buy and Strong Buy), though sentiment has deteriorated slightly from 4.69 a month ago. The current consensus includes 10 Strong Buy ratings and 3 Hold ratings with no sell recommendations, indicating broad confidence despite recent softness.

The $47.38 mean price target implies +20.5% upside from the current $39.30 price, with estimates ranging from a low of $40.00 (+1.8%) to a high of $60.00 (+52.7%). This wide target range reflects divergent views on the company's growth trajectory, with bulls seeing substantial premium format market share gains and bears concerned about box office cyclicality.

The slight deterioration in sentiment—one analyst downgrading from Strong Buy to Hold over the past month—coincides with the first quarter's flat earnings performance and suggests some reassessment of near-term expectations. However, the 13 total recommendations with zero sell ratings demonstrates that even cautious analysts see limited downside risk at current levels, viewing any weakness as a buying opportunity rather than a fundamental concern.

Part 4: Technical Picture

The Barchart Technical Opinion registers a 72% Buy signal, unchanged from last week but down from 88% Buy a month ago, reflecting some loss of momentum as the stock has consolidated near recent highs. This deterioration aligns with the stock's recent sideways trading pattern and suggests technical enthusiasm has cooled from the strong bullish readings seen in June.

Timeframe Analysis:

• Short-term (50% Buy): Moderate buy signal indicates near-term momentum has weakened considerably from the strong readings of recent months, suggesting indecision among traders heading into the earnings event
• Medium-term (100% Buy): Strong buy signal across the intermediate timeframe reflects solid underlying trend strength despite short-term consolidation
• Long-term (100% Buy): Maximum bullish reading in the longer-term view indicates the multi-month uptrend remains firmly intact

Trend Characteristics: The Soft Strengthening designation suggests the stock is attempting to rebuild momentum after a period of consolidation, though the recovery remains tentative rather than decisive.

The stock is trading at $39.30, positioned above its 5-day ($38.79), 10-day ($38.66), 50-day ($39.17), 100-day ($38.54), and 200-day ($36.94) moving averages, but below its 20-day average ($39.44). This configuration shows strong longer-term trend support but recent short-term weakness, with the stock failing to hold above its 20-day line.

The technical setup heading into earnings is cautiously supportive but vulnerable. While the stock maintains a cushion above all major long-term moving averages—particularly the critical 200-day at $36.94—the failure to hold the 20-day average and the weakening short-term momentum signal suggest limited technical conviction. The 10.93% expected move from options implies traders are pricing in a breakout from this consolidation pattern, with the $43.84 upper boundary and $35.20 lower boundary representing key levels. A beat-and-raise scenario could propel the stock toward the $47.38 analyst target, while disappointment risks a test of the 50-day support at $39.17 or even the psychologically important $36.94 level where the 200-day average provides a longer-term floor.